|
Antibody-based Targeting of Alternatively Spliced Tissue Factor in High-incidence and Recalcitrant Cancers (112-032)
As tumors are initially formed and develop, they exploit numerous proliferation, survival, angiogenesis etc signaling pathways. Full-length Tissue Factor (flTF) and Alternatively-Spliced Tissue Factor (asTF) are two glycoprotein isoforms of Tissue Factor that naturally regulate a variety of these important pathways, and are overexpressed and hijacked...
Published: 8/30/2023
|
Updated: 8/30/2023
|
Inventor(s): Henri Versteeg, Vladimir Bogdanov
Keywords(s):
Category(s): Technology Classifications > Life Sciences, Technology Classifications > Life Sciences > Biomedical
|